Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

ED, Global Clinical Operations

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that completed Phase Ib clinical trial to treat ulcerative colitis (UC), as well as induce anti-inflammatory effects in CD4+ T cells and other cells in the gastrointestinal tract. The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; and LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-02-28	Premium	sold	Premium	Premium	Premium	-
2023-02-28	Premium	sold	Premium	Premium	Premium	-
2023-02-28	Premium	sold	Premium	Premium	Premium	-
2022-09-23	Premium	sold	Premium	Premium	Premium	-
2022-08-05	Premium	gifted	Premium	Premium	Premium	-
2022-08-05	Premium	gifted	Premium	Premium	Premium	-
2022-03-23	Premium	gifted	Premium	Premium	Premium	-
2021-12-28	Premium	gifted	Premium	Premium	Premium	-
2021-12-20	Premium	sold	Premium	Premium	Premium	-
2021-12-17	Premium	sold	Premium	Premium	Premium	-
2021-12-16	Premium	gifted	Premium	Premium	Premium	-
2021-12-16	Premium	sold	Premium	Premium	Premium	-
2021-12-15	Premium	sold	Premium	Premium	Premium	-
2021-12-14	Premium	sold	Premium	Premium	Premium	-
2021-12-13	Premium	sold	Premium	Premium	Premium	-
2021-12-10	Premium	sold	Premium	Premium	Premium	-
2021-12-09	Premium	sold	Premium	Premium	Premium	-
2021-12-08	Premium	sold	Premium	Premium	Premium	-
2021-12-07	Premium	sold	Premium	Premium	Premium	-
2021-12-06	Premium	sold	Premium	Premium	Premium	-
2021-12-03	Premium	sold	Premium	Premium	Premium	-
2021-12-03	Premium	gifted	Premium	Premium	Premium	-
2021-12-02	Premium	sold	Premium	Premium	Premium	-
2021-12-01	Premium	sold	Premium	Premium	Premium	-
2021-11-30	Premium	sold	Premium	Premium	Premium	-

LABP - Landos Biopharma, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for LABP